We here report an unusual association of myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria (PNH), and diffuse large B-cell non-Hodgkin lymphoma (NHL) in a 62- year-old male.PNH is a stem cell disorder caused by a PIG-A gene mutation. As a consequence, blood cells completely or partially lack surface proteins that are tethered to the membrane through the glycosylphosphatidylinositol (GPI) anchor. The resulting absence of CD55 and CD59 molecules on red cells renders them sensitive to complement-mediated intravascular hemolysis and associated hemoglobinuria. In conclusion, in this patient, eculizumab was highly effective in controlling PNH activity and decreasing intravascular hemolysis; it greatly improved the quality of life, reduced the risk for thrombosis, and eliminated the need for blood transfusions, despite the presence of a concomitant MDS with an abnormal karyotype. Death was related due an aggressive form of high grade nHL

An unusual association of paroxysmal nocturnal hemoglobinuria, myelodysplastic syndrome, and diffuse large B-cell non-Hodgkin lymphoma in a Caucasian man

Lanza F.
Primo
Writing – Review & Editing
;
2016

Abstract

We here report an unusual association of myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria (PNH), and diffuse large B-cell non-Hodgkin lymphoma (NHL) in a 62- year-old male.PNH is a stem cell disorder caused by a PIG-A gene mutation. As a consequence, blood cells completely or partially lack surface proteins that are tethered to the membrane through the glycosylphosphatidylinositol (GPI) anchor. The resulting absence of CD55 and CD59 molecules on red cells renders them sensitive to complement-mediated intravascular hemolysis and associated hemoglobinuria. In conclusion, in this patient, eculizumab was highly effective in controlling PNH activity and decreasing intravascular hemolysis; it greatly improved the quality of life, reduced the risk for thrombosis, and eliminated the need for blood transfusions, despite the presence of a concomitant MDS with an abnormal karyotype. Death was related due an aggressive form of high grade nHL
2016
Lanza, F.; Lazzari, M. C.; Brambilla, P.; Di Martino, G.; Spedini, P.
File in questo prodotto:
File Dimensione Formato  
EPN Ann Hematol 2016 case reports.pdf

solo gestori archivio

Descrizione: Full text ahead of print
Tipologia: Full text (versione editoriale)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 420.34 kB
Formato Adobe PDF
420.34 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
2016_Article_.pdf

solo gestori archivio

Descrizione: Full text editoriale
Tipologia: Full text (versione editoriale)
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 403.14 kB
Formato Adobe PDF
403.14 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11392/2416232
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 0
social impact